These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 17425972)
21. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells. Cheema SK; Gobin AS; Rhea R; Lopez-Berestein G; Newman RA; Mathur AB Int J Pharm; 2007 Aug; 341(1-2):221-9. PubMed ID: 17499461 [TBL] [Abstract][Full Text] [Related]
22. Multifunctional polyethylenimine-conjugated superparamagnetic nanoparticles for drug delivery and imaging. Lin C; Ge J J Control Release; 2011 Nov; 152 Suppl 1():e58-60. PubMed ID: 22195926 [No Abstract] [Full Text] [Related]
23. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro]. Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633 [TBL] [Abstract][Full Text] [Related]
24. Collagen-hydroxyapatite/cisplatin drug delivery systems for locoregional treatment of bone cancer. Andronescu E; Ficai A; Albu MG; Mitran V; Sonmez M; Ficai D; Ion R; Cimpean A Technol Cancer Res Treat; 2013 Aug; 12(4):275-84. PubMed ID: 23547973 [TBL] [Abstract][Full Text] [Related]
25. Reversible cell-specific drug delivery with aptamer-functionalized liposomes. Cao Z; Tong R; Mishra A; Xu W; Wong GC; Cheng J; Lu Y Angew Chem Int Ed Engl; 2009; 48(35):6494-8. PubMed ID: 19623590 [No Abstract] [Full Text] [Related]
26. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707 [TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin. Tian J; Pang X; Yu K; Liu L; Zhou J Pharmazie; 2008 Aug; 63(8):593-7. PubMed ID: 18771008 [TBL] [Abstract][Full Text] [Related]
28. Antitumoral materials with regenerative function obtained using a layer-by-layer technique. Ficai D; Sonmez M; Albu MG; Mihaiescu DE; Ficai A; Bleotu C Drug Des Devel Ther; 2015; 9():1269-79. PubMed ID: 25767374 [TBL] [Abstract][Full Text] [Related]
29. A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents. Mirzayans R; Andrais B; Scott A; Tessier A; Murray D J Pharm Pharm Sci; 2007; 10(2):298s-311s. PubMed ID: 17718933 [TBL] [Abstract][Full Text] [Related]
30. Effect of hydroxyapatite nanoparticles on the ultrastructure and function of hepatocellular carcinoma cells in vitro. Yin MZ; Han YC; Bauer IW; Chen P; Li SP Biomed Mater; 2006 Mar; 1(1):38-41. PubMed ID: 18458384 [TBL] [Abstract][Full Text] [Related]
31. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs. Fromigué O; Hamidouche Z; Marie PJ J Pharmacol Exp Ther; 2008 May; 325(2):595-600. PubMed ID: 18252811 [TBL] [Abstract][Full Text] [Related]
32. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388 [TBL] [Abstract][Full Text] [Related]
33. Novel micelles from graft polyphosphazenes as potential anti-cancer drug delivery systems: drug encapsulation and in vitro evaluation. Zheng C; Qiu L; Yao X; Zhu K Int J Pharm; 2009 May; 373(1-2):133-40. PubMed ID: 19429298 [TBL] [Abstract][Full Text] [Related]
34. Osteotropic polypeptide nanoparticles with dual hydroxyapatite binding properties and controlled cisplatin delivery. de Miguel L; Popa I; Noiray M; Caudron E; Arpinati L; Desmaele D; Cebrián-Torrejón G; Doménech-Carbó A; Ponchel G Pharm Res; 2015 May; 32(5):1794-803. PubMed ID: 25504453 [TBL] [Abstract][Full Text] [Related]
35. [A newly designed system, "FC-UV-CDDP", and a study of its oncolytic effect]. Shindoh T; Matsuura N; Sugitachi A; Saitoh K Gan To Kagaku Ryoho; 2001 Oct; 28(11):1534-7. PubMed ID: 11707973 [TBL] [Abstract][Full Text] [Related]
36. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin]. Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689 [TBL] [Abstract][Full Text] [Related]
37. Activity of lipoplatin in tumor and in normal cells in vitro. Arienti C; Tesei A; Ravaioli A; Ratta M; Carloni S; Mangianti S; Ulivi P; Nicoletti S; Amadori D; Zoli W Anticancer Drugs; 2008 Nov; 19(10):983-90. PubMed ID: 18827563 [TBL] [Abstract][Full Text] [Related]
38. New nitrogen-containing sesquiterpenoids from the Taiwanese soft coral Cespitularia taeniata May. Cheng YB; Chen CY; Kuo YH; Shen YC Chem Biodivers; 2009 Aug; 6(8):1266-72. PubMed ID: 19697346 [TBL] [Abstract][Full Text] [Related]
39. Delivering a photosensitive transplatin prodrug to overcome cisplatin drug resistance. Song H; Li W; Qi R; Yan L; Jing X; Zheng M; Xiao H Chem Commun (Camb); 2015 Jul; 51(57):11493-5. PubMed ID: 26094840 [TBL] [Abstract][Full Text] [Related]
40. [Influence of SNCG transfection on the effectiveness of anti-tumor drugs in PC-3 cell lines]. Chen JL; Wang B; Zhang LR; He BS; Pan YQ; Zeng QD; Jiang HX; Wang SK Zhonghua Nan Ke Xue; 2008 Dec; 14(12):1077-82. PubMed ID: 19157226 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]